Free Trial

Precision BioSciences (DTIL) SEC Filings & 10K Form

Precision BioSciences logo
$5.02 +0.01 (+0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$5.01 0.00 (-0.10%)
As of 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Precision BioSciences SEC Filings

DateFilerForm TypeView
08/14/2025
3:09 PM
Precision BioSciences (Subject)
Readout Capital, LP (Filed by)
Form SCHEDULE 13G/A
08/14/2025
10:14 AM
Bleichroeder LP (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G
08/07/2025
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:31 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:30 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:25 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2025
5:14 AM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
5:14 AM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
6:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
6:34 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2025
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
3:45 PM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
1:16 PM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G/A
04/15/2025
7:08 AM
Precision BioSciences (Filer)
Form DEF 14A
04/15/2025
7:09 AM
Precision BioSciences (Filer)
Form DEFA14A
04/15/2025
7:10 AM
Precision BioSciences (Filer)
Form ARS
04/04/2025
6:38 AM
Precision BioSciences (Filer)
Form PRE 14A
03/28/2025
6:00 AM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
6:02 AM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
6:00 AM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
5:09 PM
Precision BioSciences (Subject)
Readout Capital, LP (Filed by)
Form SCHEDULE 13G
03/26/2025
4:03 PM
Precision BioSciences (Filer)
Form 424B5
03/26/2025
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM
Precision BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2025
5:00 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
2:13 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
4:13 PM
Precision BioSciences (Subject)
Weinstein Benjamin (Filed by)
Form SCHEDULE 13G
03/07/2025
3:30 PM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
6:00 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:00 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:00 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
2:17 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
3:13 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
10:59 AM
Aquilo Capital Management, LLC (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:35 AM
JANUS HENDERSON GROUP PLC (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:01 AM
Lynx1 Capital Management LP (Filed by)
Precision BioSciences (Subject)
Form SCHEDULE 13G
01/29/2025
6:30 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
2:10 PM
List Alan (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
8:00 PM
Precision BioSciences (Issuer)
SMITH J. JEFFERSON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:00 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)

On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel

Click here to download the guide and protect your assets before Sept 15th.
01/22/2025
8:00 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
8:00 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:13 PM
Precision BioSciences (Subject)
SMITH J. JEFFERSON (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:14 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:19 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:05 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM
Germano Geno J (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
6:00 AM
Buehler Kevin (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:10 AM
Brown Melinda (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G/A
11/14/2024
10:00 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Precision BioSciences (Subject)
Form SC 13G
11/05/2024
6:14 PM
Amoroso Michael (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Precision BioSciences (Issuer)
Scimeca Dario (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:14 PM
Kelly John Alexander (Reporting)
Precision BioSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:49 PM
Amoroso Michael (Reporting)
Precision BioSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
2:51 PM
Precision BioSciences (Subject)
Scimeca Dario (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
6:15 AM
Precision BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
7:45 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:00 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:03 AM
Precision BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DTIL) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners